Celldex Therapeutics, Inc. (CLDX): Price and Financial Metrics
Celldex Therapeutics, Inc. (CLDX)
Today's Latest Price: $21.25 USD
1.33 (6.68%)
Updated Nov 23 6:55pm
Add CLDX to WatchlistSign Up
POWR Components:
Trade Grade Buy & Hold Grade Peer Grade Industry Rank
Industry Rank:
See all "A" rated Strong Buy stocks
CLDX Stock Summary
- With a one year PEG ratio of 635.46, Celldex Therapeutics Inc is expected to have a higher PEG ratio (a measure of how expensive a stock is relative to its expected earnings growth) than 94.12% of US stocks.
- With a price/sales ratio of 174.41, Celldex Therapeutics Inc has a higher such ratio than 97.88% of stocks in our set.
- The volatility of Celldex Therapeutics Inc's share price is greater than that of 96.95% US stocks with at least 200 days of trading history.
- If you're looking for stocks that are quantitatively similar to Celldex Therapeutics Inc, a group of peers worth examining would be PULM, EVGN, CBIO, ARCT, and PIRS.
- Visit CLDX's SEC page to see the company's official filings. To visit the company's web site, go to www.celldex.com.
CLDX Stock Price Chart Interactive Chart >
CLDX Price/Volume Stats
| Current price | $21.25 | 52-week high | $21.70 |
| Prev. close | $19.92 | 52-week low | $1.50 |
| Day low | $19.96 | Volume | 1,419,600 |
| Day high | $21.70 | Avg. volume | 1,151,235 |
| 50-day MA | $16.31 | Dividend yield | N/A |
| 200-day MA | $8.82 | Market Cap | 840.80M |
Celldex Therapeutics, Inc. (CLDX) Company Bio
Celldex Therapeutics is developing targeted therapeutics to address devastating diseases for which available treatments are inadequate. The company was founded in 2004 and is based in Hampton, New Jersey.
Loading social stream, please wait...